Showing posts with label abiraterone. Show all posts
Showing posts with label abiraterone. Show all posts

Aug 13, 2012

Video: abiraterone and enzalutamide for advanced prostate cancer: results from ASCO 2012 discussed

A video summary of the most important data regarding abiraterone (Zytiga ®) and enzalutamide (MDV-3100) - two of the most important new drugs in prostate cancer.  Recorded at ASCO 2012.


To put a smile on your face see Larry's latest cartoon.
To learn more about clinical trials, take a look at our book.

(c) 2012 Tom Beer and Larry Axmaker

May 9, 2012

Video: Latest Developments in Advanced Prostate Cancer Treatment with Dr. Beer

A comprehensive discussion on all the principal current treatments and the most promising emerging drugs for advanced prostate cancer.  In this talk, we discuss hormonal agents including abiraterone and MDV-3100, chemotherapy drugs including docetaxel and cabazitaxel, immunologic therapy with sipuleucel-T, biologic therapy with XL-184, and bone targeted therapy with alpharadin.  We then put it altogether to offer a vision for the treatment paradigm of the near future.


For those of you that watched the previously posted talk, this one is a bit more inclusive and comprehensive.  It is a different program that was put together with the team at Medscape.








To see the entire program and slides, you will need to go the Medscape website.  You will likely need to sign up to be a member of Medscape to get full access to these materials.  There is no cost to doing this.


To learn more about clinical trials, take a look at our book.
To put a smile on your face see Larry's latest cartoon.


(c) 2012 Tom Beer and Larry Axmaker